The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I think that Lloyd is right- and deserves his place on the BB as much as the next person.
Whenever this share shoots up in price you get a whole bunch of Newbies appear on here who just don’t have the experience of how this share moves.
Hello Mr India, I don’t understand why you think Budd did the wrong thing about quashing the rumours about the Indian market. It was the responsible thing for him to have done IMO. If he had said nothing, more investors would have been pulled in, pushing up the share price, only for it to come down again anyway when the truth was revealed.
That’s my view anyway… If you disagree then fine.
I am massively under too, and now doubt I’ll get my money back and am bitterly disappointed that the company has failed to deliver on its COVID potentialbut I can’t blame Budd for making it clear there were no in the rumours, he did the right thing there. All IMHO.
Rags rob, I agree… a lot of very uninformed views on here I’m so disappointed in some of the posters who I thought were pretty intelligent.
It’s put me off the York get together for sure.
Think we should stick to EUA matters as this thread is a disgrace.
Jimi, getting a decent sales director in will likely take at least 6 months. Unfortunately I think we’re in for the long haul before we see much in the way of significant progress on sales, although think we should definitely see some sales from the NHS trusts involved in the trial as a minimum.
I hope they get it all in place and functioning to avoid another cash call in a years time. Or were all ******.
Frankly, do you think therefore that Budd has to go… his shelf life has expired now that the company is supposedly in a commercial phase? He just can’t make that transition. There’s a world of difference between marketing and selling IMO.
Hiring in a sales director, plus his team of 7 people is not going to be cheap or happen quickly, and not guaranteed to work either.
Presumably the chairman needs to step up to the plate and find a replacement CEO before it gets to a shareholder vote to remove him from office?
I agree with other posters that the amount Budd is being paid is astonishing.
Starresnstoff… agreed it is not going to be overnight.
Do you not think Beckman would be the US distributor?
I am of the opinion that the US will adopt the test earlier rather than later. I should think hospitals would adopt to avoid lawsuits, at the very least, and as best practice for babies needing antibiotics.
I’m actually very proud to be invested in a company that is poised to do so much good. I know we shouldn’t fall in love with a share but too late for me!
Does anyone have an idea of the size of the potential market?
I think I remember a post last year saying 65m annual sales?
Anyone have an idea of the Gross profit on that? I think people on this board were saying 75- 65% Gp on the Covid test. From this distribution costs need to be deducted. I have no idea how much those are in the diagnostics industry… anyone else?
I think patience is the key here, like it has been over at Eurasia. That and trust your own research.
I’m already heavily in this share but thinking about putting more in at these ridiculous low levels. Once sales figures start to be announced for the AIhl test, as it will, the returns will be massive.
Portsmouth… wishing you all the best for your operation and recovery.
Ohmi.. what a terrible time you’ve had and I hope it all comes good for you.
I think it shows all of us have stuff going on off this board in our real lives, some of it life-changing , and to be as kind as possible.